All cells contain proteases which effect catalytic hydrolysis of the peptide bond between amino acids in the protein backbone. Typically, proteinases are prevented from non-specific proteolysis by regulation and physical separation into different sub-cellular compartments; however, this segregation is not retained during cell lysis to release a protein of interest. Prevention of proteolysis during protein purification often takes the form of a two-pronged approach; firstly inhibition of proteolysis in situ, followed by the separation of the protease from the protein of interest via chromatographical purification. Proteinase inhibitors are routinely used to limit the effect of the proteinases before they are physically separated from the protein of interest via column chromatography. Here, commonly used approaches to reducing proteolysis during chromatography are reviewed.
1.

Introduction
Protein stability can be defined as "the persistence of molecular integrity or biological function despite adverse influences or conditions, such as heat or other deleterious conditions" (1). One of the key deleterious conditions during protein chromatography is the presence of proteolytic substances, often referred to as proteases. Proteolysis is the directed degradation of proteins by specific proteases. Proteases have been referred to as "Nature's Swiss Army knife" due to their diverse applications in protein cleavage (2) . Proteases belong to the hydrolase class of enzyme Metalloproteinases contain a catalytic mechanism involving a metal; most contain zinc, however, cobalt centres are also observed. Adamalysin (EC 3.4.24.46, an endopeptidase from the rattlesnake Crotalus adamanteus) is an example of a metalloproteinase (8).
Proteases are employed by all living cells to maintain a particular rate of protein turnover by continuous degradation and synthesis of proteins. Catabolism of proteins provides a ready pool of amino acids that can be reused as precursors for protein synthesis. Intracellular proteases participate in executing correct protein turnover for the cell: in E. coli, the ATP-dependent protease La, the lon gene product, is responsible for hydrolysis of abnormal proteins (9). The turnover of intracellular proteins in eukaryotes is also affected by a pathway involving ATPdependent proteases (10).
As such, proteases are essential components in all life forms and in normal circumstances proteases are typically packaged into specialised organelles to minimise the chance of nonspecific proteolytic activity. Within these organelles there are specific regulators associated with each protease, controlling the action of the protease. However, when cells are disrupted for chromatography purification, proteases that are normally located in a different sub-cellular compartment are separated from their regulator molecules and exposed to the protein of interest, thus increasing the probability of undesired proteolysis (11). Realistically, it is impossible to remove all proteinases present in a chromatography sample preparation, however, careful Proteases are ubiquitous and play a crucial role in normal and abnormal physiological conditions in all living things by effecting catalysis throughout many metabolic pathways. However, there is an uneven distribution of proteinases depending on which cell type (bacterial or eukaryotic) or tissue is disrupted. During heterologous protein expression, the recombinant protein of interest may be exposed to a host proteinase to which it is particularly susceptible. Simply altering the host may reduce recombinant proteolysis. Many commercial companies offer protease deficient strains for heterologous protein expression; for example E. coli BL21, is deficient in two proteases encoded by the lon (cytoplasmic protease) and ompT (periplasmic protease) genes (see Table 1 ). Additionally in mammalian tissues, liver and kidney samples contain a much higher concentration of proteolytic enzymes compared to skeletal or cardiac muscle (12). Once the source of the protein of choice has been optimized, a commonly used approach toward prevention of further unwanted proteolysis during protein isolation is to include proteinase inhibitors during sample preparation, purification, and characterization.
INSERT TABLE ONE ABOUT HERE
Proteinase Inhibitor Selection and Preparation.
Judicious inhibitor choice will depend on the correct empirical identification of the proteinase involved. Classification of the proteinase(s) can be carried out in several ways, however, the simplest method is to incubate the sample of choice with a single inhibitor from the group of inhibitors (Serine, Cysteine, Thiol etc.) listed in Table 2 . The degree of proteolysis can be identified from Sodium Dodecyl Sulfate PolyAcrylamide Gel Electrophoresis (SDS PAGE) analysis of the protein sample post inhibitor incubation; increased protein band smearing on the gel or a change in expected protein size will indicate potential proteolysis. Proteolysis inhibition, indicated by a maintenance of correct protein size with no protein band smearing after a given incubation period with inhibitor, will permit the identification of a suitable inhibitor group for the sample preparation. Once the protease has been identified, individual inhibitors can be chosen from Table 2 or a typical general-use proteinase inhibitor mix can be prepared immediately before use from the stock concentrations outlined in Table 3 . Proteinase inhibitor solutions must be correctly stored after they have been prepared. Aliquot the stock of inhibitor and store at the correct temperature (see Table 2 ) to maintain the properties of the inhibitor.
Make small, single use aliquots to reduce the risk of stock contamination. Ensure that the proteinase inhibitor/inhibitor mix is combined with the cell sample prior to cell disruption. If the individual proteinase inhibitor/inhibitor mix is to be prepared fresh then it must be used within one hour of preparation.
INSERT TABLE TWO ABOUT HERE.
INSERT TABLE THREE ABOUT HERE.
It should be noted that the generic proteinase inhibitor cocktail outlined here is not guaranteed to work in all circumstances. The success of any mix will depend on the correct empirical identification of the proteinase involved.
Commercially available Universal Protease Inhibitor Mixes.
There are several types of commercially available "Universal Proteinase Inhibitors" that may also be used (e.g. Complete Protease Inhibitor Cocktail Tablets, Roche Applied Science).
Additionally, many companies offer inhibitor panels, such as the Protease Inhibitor Panel (Sigma Aldrich), which is a cost-effective method for personalized proteinase cocktail inhibitor generation (13).
Supplementary Protease Inhibitor Components.
Additional Inhibitors
If a particular protease is dominant within a sample preparation the cocktail mix may be supplemented with additional specific proteinase inhibitors (12,14 -21). Commonly used specific individual protease inhibitor components are outlined in Table 4 .
INSERT TABLE FOUR ABOUT HERE.
Phosphatase inhibitors may be required also as many enzymes are activated by phosphorylation, hence dephosphorylation must be inhibited if enzyme activity is to be maintained. Again, an empirical approach is required to identify if a phosphatase inhibitor is required (see Section 1.1
and 
Supplementary Chemical Compounds including Enzymes.
The addition of supplementary chemical components to disrupt proteinase activity first should be carefully assessed on a small scale as often these components will alter the function/stability of the target protein (see Table 6 ). Furthermore, additional protease inhibitors should be introduced to the sample with caution as protein modifications, such as alteration of protein charge, may occur. These alterations may interfere with further protein characterisation studies. For example, 2-mercaptoethanol will reduce the activity of cysteine proteinases, but will also unfold target proteins containing disulphide bridges. EDTA is included in many proteinase inhibitor buffers as metal ions are frequently involved in proteolysis, thus their removal will impede proteolysis.
However, if one is purifying poly-Histidine tagged proteins or metalloproteins, then the chelating effect of EDTA will dramatically alter purification yields, and the EDTA should be removed from the buffer by dialysis or a buffer exchange resin. Inclusion of 2 M thiourea may also prevent proteolyis. Castellanos-Serra and Paz-Lago (23) noted the proteolysis inhibitory effects of its addition in conjunction with its efficiency in solubilizing proteins. DNase (100 U/mL), although not itself a protease inhibitor, can be included in the cell lysis buffer as this will reduce the overall viscosity of the crude lysate. The reaction is allowed to proceed for 10 min at 4°C in the presence of 10 mM MgCl 2 .
INSERT TABLE SIX ABOUT HERE.
Protease Inhibition During Chromatography.
The introduction of contaminating proteases from your own skin, non-sterile water etc. can be avoided by sterilising all plasticware and by wearing appropriate personal protective equipment.
All buffers should be sterile filtered (0.2 µm) into autoclaved bottles (sterile filtering will not remove contaminating proteases, but will remove any protease secreting microorganisms).
Additionally, sterile filter the protein eluate once purification is complete.
Cell disruption, as with all other parts of the purification procedure, should take place at 2-8 o C.
This temperature will not only reduce the activity of proteinases, but will also aid in stabilizing the target protein (reduction in thermal denaturation). Kulakowska-Bodzon and co-workers (24)
provide an excellent review on protein preparation from various cell types for proteomic work.
In general, all buffers and materials should be pre-chilled to 2-8 o C. Rapid purification at this lower temperature will reduce the risk of unwanted proteolysis. Do not store such samples at 2-8 o C for more than one day between purification steps, instead store at -20°C.
Gel filtration (size exclusion chromatography, see Chapter 2) is often used as the final step in protein purification and it can be used to desalt and buffer exchange the protein (therefore no need for dialysis). Contaminating proteinases can also be separated from the protein of choice if there is significant separation between elution peaks for the protease and the protein of choice.
This is based on the presumption that there is a considerable difference between the size of the protease and the size of the protein of interest.
Post Chromatography Analysis.
Protease inhibition can be either reversible or irreversible. The majority of serine and cysteine proteinase inhibitors are irreversible, whereas the aspartic and metalloproteinase inhibitors are reversible. Even when the inhibitors are added at an early stage, they may be lost during purification and subsequent handling steps, resulting in proteolysis post-purification. The further re-addition of proteinase inhibitors may therefore be required after purification.
Even with increased numbers of purification steps, very few protocols will remove all contaminants from a sample preparation however one can achieve an adequate reduction in the level of these contaminants. Each purification protocol will have a unique definition of 
Conclusion.
The presence of proteolytic enzymes can result in target protein degradation during protein chromatography. Careful selection of source organism/tissue, along with judicious use of protease inhibitors, can reduce these degrading effects. Commonly used inhibitors are listed here in tabular format (see Tables 3 and 4) , along with supplemental compounds (see Tables 5 and 6) for easy selection. Protease inhibitors can be added individually or as part of a mix, however, optimal inhibitor selection is an empirical process. 
